http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 21 Aug 2026 06:03:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++425++++++++ENDRA+Life+Sciences+Inc.+++++++++++++++Filed+by%3A+ASP+Isotopes+Inc./26958112.html si-local-file:///var/storage/secattach/20260821/26958112.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++ENDRA+Life+Sciences+Inc.+++++++++++++++Filed+by%3A+ASP+Isotopes+Inc./26958112.html Fri, 21 Aug 2026 06:03:00 -0400 NDRA O.30741434 http://www.streetinsider.com/SEC+Filings/Form++425++++++++ENDRA+Life+Sciences+Inc.+++++++++++++++Filed+by%3A+ASP+Isotopes+Inc./26958112.html si-local-file:///var/storage/secattach/20260821/26958112.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++ENDRA+Life+Sciences+Inc.+++++++++++++++Filed+by%3A+ASP+Isotopes+Inc./26958112.html Fri, 21 Aug 2026 06:03:00 -0400 NDRA O.30741434 http://www.streetinsider.com/SEC+Filings/Form++425++++++++ENDRA+Life+Sciences+Inc.+++++++++++++++Filed+by%3A+ASP+Isotopes+Inc./26953316.html si-local-file:///var/storage/secattach/20260820/26953316.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++ENDRA+Life+Sciences+Inc.+++++++++++++++Filed+by%3A+ASP+Isotopes+Inc./26953316.html Thu, 20 Aug 2026 08:10:00 -0400 NDRA O.30741434 http://www.streetinsider.com/SEC+Filings/Form++425++++++++ENDRA+Life+Sciences+Inc.+++++++++++++++Filed+by%3A+ASP+Isotopes+Inc./26953316.html si-local-file:///var/storage/secattach/20260820/26953316.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++ENDRA+Life+Sciences+Inc.+++++++++++++++Filed+by%3A+ASP+Isotopes+Inc./26953316.html Thu, 20 Aug 2026 08:10:00 -0400 NDRA O.30741434 http://www.streetinsider.com/SEC+Filings/Form++425++++++++ENDRA+Life+Sciences+Inc.+++++++++++++++Filed+by%3A+ENDRA+Life+Sciences+Inc./26938003.html si-local-file:///var/storage/secattach/20260817/26938003.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++ENDRA+Life+Sciences+Inc.+++++++++++++++Filed+by%3A+ENDRA+Life+Sciences+Inc./26938003.html Mon, 17 Aug 2026 16:07:00 -0400 NDRA O.30741434 http://www.streetinsider.com/SEC+Filings/Form++425++++++++ENDRA+Life+Sciences+Inc.+++++++++++++++Filed+by%3A+ENDRA+Life+Sciences+Inc./26938003.html si-local-file:///var/storage/secattach/20260817/26938003.html http://www.streetinsider.com/SEC+Filings/Form++425++++++++ENDRA+Life+Sciences+Inc.+++++++++++++++Filed+by%3A+ENDRA+Life+Sciences+Inc./26938003.html Mon, 17 Aug 2026 16:07:00 -0400 NDRA O.30741434 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ENDRA+Life+Sciences+Inc.++For%3A+Aug+17/26937966.html si-local-file:///var/storage/secattach/20260817/26937966.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ENDRA+Life+Sciences+Inc.++For%3A+Aug+17/26937966.html Mon, 17 Aug 2026 16:06:00 -0400 NDRA O.30741434 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ENDRA+Life+Sciences+Inc.++For%3A+Aug+17/26937966.html si-local-file:///var/storage/secattach/20260817/26937966.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++ENDRA+Life+Sciences+Inc.++For%3A+Aug+17/26937966.html Mon, 17 Aug 2026 16:06:00 -0400 NDRA O.30741434 http://www.streetinsider.com/Press+Releases/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html <p> ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc.<b> (NASDAQ: NDRA) </b>(“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><p> On June 25, 2026, ENDRA entered into a <b>definitive merger agreement with ASP Isotopes Inc.</b> (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , Renergen Limited and other parties thereto. Under the terms of the agreement, Noble Africa will merge with a wholly owned subsidiary of ENDRA, with Noble http://www.streetinsider.com/Press+Releases/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html Mon, 17 Aug 2026 08:00:00 -0400 A.03889711 A.06822034 ASPI NDRA O.20026344 O.24810529 O.30741434 O.56005667 http://www.streetinsider.com/Press+Releases/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html <p> ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc.<b> (NASDAQ: NDRA) </b>(“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><p> On June 25, 2026, ENDRA entered into a <b>definitive merger agreement with ASP Isotopes Inc.</b> (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , Renergen Limited and other parties thereto. Under the terms of the agreement, Noble Africa will merge with a wholly owned subsidiary of ENDRA, with Noble http://www.streetinsider.com/Press+Releases/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html Mon, 17 Aug 2026 08:00:00 -0400 A.03889711 A.06822034 ASPI NDRA O.20026344 O.24810529 O.30741434 O.56005667 http://www.streetinsider.com/Press+Releases/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html <p> ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc.<b> (NASDAQ: NDRA) </b>(“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><p> On June 25, 2026, ENDRA entered into a <b>definitive merger agreement with ASP Isotopes Inc.</b> (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , Renergen Limited and other parties thereto. Under the terms of the agreement, Noble Africa will merge with a wholly owned subsidiary of ENDRA, with Noble http://www.streetinsider.com/Press+Releases/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html Mon, 17 Aug 2026 08:00:00 -0400 A.03889711 A.06822034 ASPI NDRA O.20026344 O.24810529 O.30741434 O.56005667 http://www.streetinsider.com/Press+Releases/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html <p> ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc.<b> (NASDAQ: NDRA) </b>(“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><p> On June 25, 2026, ENDRA entered into a <b>definitive merger agreement with ASP Isotopes Inc.</b> (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , Renergen Limited and other parties thereto. Under the terms of the agreement, Noble Africa will merge with a wholly owned subsidiary of ENDRA, with Noble http://www.streetinsider.com/Press+Releases/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html Mon, 17 Aug 2026 08:00:00 -0400 A.03889711 A.06822034 ASPI NDRA O.20026344 O.24810529 O.30741434 O.56005667 http://www.streetinsider.com/Press+Releases/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html <p> ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc.<b> (NASDAQ: NDRA) </b>(“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><p> On June 25, 2026, ENDRA entered into a <b>definitive merger agreement with ASP Isotopes Inc.</b> (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , Renergen Limited and other parties thereto. Under the terms of the agreement, Noble Africa will merge with a wholly owned subsidiary of ENDRA, with Noble http://www.streetinsider.com/Press+Releases/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html Mon, 17 Aug 2026 08:00:00 -0400 A.03889711 A.06822034 ASPI NDRA O.20026344 O.24810529 O.30741434 O.56005667 http://www.streetinsider.com/Press+Releases/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html <p> ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc.<b> (NASDAQ: NDRA) </b>(“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><p> On June 25, 2026, ENDRA entered into a <b>definitive merger agreement with ASP Isotopes Inc.</b> (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , Renergen Limited and other parties thereto. Under the terms of the agreement, Noble Africa will merge with a wholly owned subsidiary of ENDRA, with Noble http://www.streetinsider.com/Press+Releases/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html Mon, 17 Aug 2026 08:00:00 -0400 A.03889711 A.06822034 ASPI NDRA O.20026344 O.24810529 O.30741434 O.56005667 http://www.streetinsider.com/Press+Releases/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html <p> ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc.<b> (NASDAQ: NDRA) </b>(“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><p> On June 25, 2026, ENDRA entered into a <b>definitive merger agreement with ASP Isotopes Inc.</b> (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , Renergen Limited and other parties thereto. Under the terms of the agreement, Noble Africa will merge with a wholly owned subsidiary of ENDRA, with Noble http://www.streetinsider.com/Press+Releases/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html Mon, 17 Aug 2026 08:00:00 -0400 A.03889711 A.06822034 ASPI NDRA O.20026344 O.24810529 O.30741434 O.56005667 http://www.streetinsider.com/Press+Releases/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html <p> ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc.<b> (NASDAQ: NDRA) </b>(“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><p> On June 25, 2026, ENDRA entered into a <b>definitive merger agreement with ASP Isotopes Inc.</b> (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , Renergen Limited and other parties thereto. Under the terms of the agreement, Noble Africa will merge with a wholly owned subsidiary of ENDRA, with Noble http://www.streetinsider.com/Press+Releases/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html Mon, 17 Aug 2026 08:00:00 -0400 A.03889711 A.06822034 ASPI NDRA O.20026344 O.24810529 O.30741434 O.56005667 http://www.streetinsider.com/Business+Wire/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html <p> ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc.<b> (NASDAQ: NDRA) </b>(“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><p> On June 25, 2026, ENDRA entered into a <b>definitive merger agreement with ASP Isotopes Inc.</b> (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , Renergen Limited and other parties thereto. Under the terms of the agreement, Noble Africa will merge with a wholly owned subsidiary of ENDRA, with Noble http://www.streetinsider.com/Business+Wire/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html Mon, 17 Aug 2026 08:00:00 -0400 A.03889711 A.06822034 ASPI NDRA O.20026344 O.24810529 O.30741434 O.56005667 http://www.streetinsider.com/Business+Wire/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html <p> ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc.<b> (NASDAQ: NDRA) </b>(“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><p> On June 25, 2026, ENDRA entered into a <b>definitive merger agreement with ASP Isotopes Inc.</b> (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , Renergen Limited and other parties thereto. Under the terms of the agreement, Noble Africa will merge with a wholly owned subsidiary of ENDRA, with Noble http://www.streetinsider.com/Business+Wire/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html Mon, 17 Aug 2026 08:00:00 -0400 A.03889711 A.06822034 ASPI NDRA O.20026344 O.24810529 O.30741434 O.56005667 http://www.streetinsider.com/Business+Wire/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html <p> ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc.<b> (NASDAQ: NDRA) </b>(“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><p> On June 25, 2026, ENDRA entered into a <b>definitive merger agreement with ASP Isotopes Inc.</b> (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , Renergen Limited and other parties thereto. Under the terms of the agreement, Noble Africa will merge with a wholly owned subsidiary of ENDRA, with Noble http://www.streetinsider.com/Business+Wire/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html Mon, 17 Aug 2026 08:00:00 -0400 A.03889711 A.06822034 ASPI NDRA O.20026344 O.24810529 O.30741434 O.56005667 http://www.streetinsider.com/Business+Wire/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html <p> ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc.<b> (NASDAQ: NDRA) </b>(“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><p> On June 25, 2026, ENDRA entered into a <b>definitive merger agreement with ASP Isotopes Inc.</b> (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , Renergen Limited and other parties thereto. Under the terms of the agreement, Noble Africa will merge with a wholly owned subsidiary of ENDRA, with Noble http://www.streetinsider.com/Business+Wire/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html Mon, 17 Aug 2026 08:00:00 -0400 A.03889711 A.06822034 ASPI NDRA O.20026344 O.24810529 O.30741434 O.56005667 http://www.streetinsider.com/Business+Wire/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html <p> ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc.<b> (NASDAQ: NDRA) </b>(“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><p> On June 25, 2026, ENDRA entered into a <b>definitive merger agreement with ASP Isotopes Inc.</b> (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , Renergen Limited and other parties thereto. Under the terms of the agreement, Noble Africa will merge with a wholly owned subsidiary of ENDRA, with Noble http://www.streetinsider.com/Business+Wire/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html Mon, 17 Aug 2026 08:00:00 -0400 A.03889711 A.06822034 ASPI NDRA O.20026344 O.24810529 O.30741434 O.56005667 http://www.streetinsider.com/Business+Wire/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html <p> ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc.<b> (NASDAQ: NDRA) </b>(“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><p> On June 25, 2026, ENDRA entered into a <b>definitive merger agreement with ASP Isotopes Inc.</b> (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , Renergen Limited and other parties thereto. Under the terms of the agreement, Noble Africa will merge with a wholly owned subsidiary of ENDRA, with Noble http://www.streetinsider.com/Business+Wire/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html Mon, 17 Aug 2026 08:00:00 -0400 A.03889711 A.06822034 ASPI NDRA O.20026344 O.24810529 O.30741434 O.56005667 http://www.streetinsider.com/Business+Wire/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html <p> ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc.<b> (NASDAQ: NDRA) </b>(“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><p> On June 25, 2026, ENDRA entered into a <b>definitive merger agreement with ASP Isotopes Inc.</b> (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , Renergen Limited and other parties thereto. Under the terms of the agreement, Noble Africa will merge with a wholly owned subsidiary of ENDRA, with Noble http://www.streetinsider.com/Business+Wire/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html Mon, 17 Aug 2026 08:00:00 -0400 A.03889711 A.06822034 ASPI NDRA O.20026344 O.24810529 O.30741434 O.56005667 http://www.streetinsider.com/Business+Wire/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html <p> ANN ARBOR, Mich.--(BUSINESS WIRE)-- ENDRA Life Sciences Inc.<b> (NASDAQ: NDRA) </b>(“ENDRA” or the “Company”), a pioneer in thermoacoustic biomarker imaging for early detection and monitoring of steatotic liver disease (SLD), reported financial results for the quarter ended June 30, 2026, and provided a business update. </p><p> <b>Second Quarter 2026 and Recent Highlights</b> </p><p> On June 25, 2026, ENDRA entered into a <b>definitive merger agreement with ASP Isotopes Inc.</b> (NASDAQ: ASPI), Noble Africa LLC (“Noble Africa”) , Renergen Limited and other parties thereto. Under the terms of the agreement, Noble Africa will merge with a wholly owned subsidiary of ENDRA, with Noble http://www.streetinsider.com/Business+Wire/ENDRA+Life+Sciences+Reports+Second+Quarter+2026+Financial+Results+and+Provides+Business+Update/26935033.html Mon, 17 Aug 2026 08:00:00 -0400 A.03889711 A.06822034 ASPI NDRA O.20026344 O.24810529 O.30741434 O.56005667 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++ENDRA+Life+Sciences+Inc.++For%3A+Jun+30/26930331.html si-local-file:///var/storage/secattach/20260814/26930331.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++ENDRA+Life+Sciences+Inc.++For%3A+Jun+30/26930331.html Fri, 14 Aug 2026 16:10:00 -0400 NDRA O.30741434